Overcoming the Limitations of Conventional Cell Engineering
RARECast - Ein Podcast von RARECast - Donnerstags
Kategorien:
Murat Kalayoglu, president and CEO of Cartesian Therapeutics, discusses the company’s RNA-engineered cell therapies, how they work, and how the company is pushing the use of cell therapies beyond cancer.
